Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections (REMDECO-19)

Clinical Trial ID NCT04365725

Rank	Title	Journal	Year	PubWeight™‹?›
1	Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.	Lancet	2020	18.32
2	Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.	Lancet	2020	10.16
3	Clinical Characteristics of Coronavirus Disease 2019 in China.	N Engl J Med	2020	9.53
4	Compassionate Use of Remdesivir for Patients with Severe Covid-19.	N Engl J Med	2020	5.15
5	A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.	Lancet	2020	3.90
6	Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques.	Proc Natl Acad Sci U S A	2013	2.29
7	Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.	Lancet	2020	2.03
8	Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys.	Nature	2016	1.38
9	GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses.	Sci Rep	2017	0.80
10	Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.	Sci Transl Med	2017	0.75